Skip to main content
Log in

Risk factors in patients with herpes zoster infections: case-control study

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

The aim of this study was to determine the prevalence of chronic disease and the risk factors for herpes zoster infection. In this case-control study medical records were collected from 55 patients who presented with herpes zoster and 54 patients in a control group who presented with gastroenterocolitis. Both groups were treated at the Clinic for Infectious Diseases, University Clinical Hospital Mostar from January, 2005 to December, 2010. When we compared the herpes zoster group with the control group, we did not demonstrate any significant difference in the overall prevalence of chronic diseases. However, the prevalence of diabetes and cancer was statistically higher when compared to the control group. A statistically significant difference in the number of cigarette smokers was not observed, whereas the number who consumed alcohol in the herpes zoster group was significantly higher compared to the control group. The correlation between alcohol and herpes zoster could help in solving the reactivation mechanism of VZV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cohen J.I., The varicella-zoster virus genome, Curr Top Microbiol Immunol, 2010, 342, 1–14 DOI: 10.1007/82_2010_10

    Article  PubMed  CAS  Google Scholar 

  2. Seward J., Jumaan A., VSV: persistence in the population, In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P. S., Roizman B., Whitley R. et al. (Eds), Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge: Cambridge University Press, 2007

    Google Scholar 

  3. Moffat J., Ku C.C., Zerboni L., Sommer M., Arvin A., VZV: pathogenesis and the disease consequences of primary infection, In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P. S., Roizman B., Whitley R. et al. (Eds), Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge: Cambridge University Press, 2007

    Google Scholar 

  4. Liesegang T.J., Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity, Ophthalmology, 2008, 115, S3–12 DOI: 10.1016/j.ophtha.2007.10.009

    Article  PubMed  Google Scholar 

  5. Arvin A., Abendroth A., VZV: immunobiology and host response, In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P. S., Roizman B., Whitley R. et al. (Eds), Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge: Cambridge University Press 2007

    Google Scholar 

  6. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al., Epidemiology of varicella zoster virus infection in Canada and the United Kingdom, Epidemiol Infect, 2001, 127, 305–314

    Article  PubMed  CAS  Google Scholar 

  7. Glynn C., Crockford G., Gavaghan D., Cardno P., Price D., Miller J., Epidemiology of shingles, J R Soc Med, 1990, 83, 617–619

    PubMed  CAS  Google Scholar 

  8. Wareham D.W., Breuer J., Herpes zoster, BMJ, 2007, 334, 1211–1215 DOI: 10.1136/bmj.39206.571042.AE

    Article  PubMed  Google Scholar 

  9. Liesegang T.J., Herpes zoster virus infection, Curr Opin Ophthalmol, 2004, 15, 531–536

    Article  PubMed  Google Scholar 

  10. van Wijck A.J., Wallace M., Mekhail N., van Kleef M., Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia, Pain Pract, 2011, 11, 88–97 DOI: 10.1111/j.1533-2500.2010.00428.x

    Article  PubMed  Google Scholar 

  11. Chidiac C., Bruxelle J., Daures J.P., Hoang-Xuan T., Morel P., Leplege A., et al., Characteristics of patients with herpes zoster on presentation to practitioners in France, Clin Infect Dis, 2001, 33, 62–69 DOI: 10.1086/320884

    Article  PubMed  CAS  Google Scholar 

  12. Thomas S.L., Hall A.J., What does epidemiology tell us about risk factors for herpes zoster?, Lancet Infect Dis, 2004, 4, 26–33

    Article  PubMed  Google Scholar 

  13. Leung J., Harpaz R., Baughman A.L., Heath K., Loparev V., Vazquez M., et al., Evaluation of laboratory methods for diagnosis of varicella, Clin Infect Dis, 2010, 51, 23–32 DOI: 10.1086/653113

    Article  PubMed  CAS  Google Scholar 

  14. Opstelten W., Eekhof J., Neven A.K., Verheij T., Treatment of herpes zoster, Can Fam Physician, 2008, 54, 373–377

    PubMed  Google Scholar 

  15. Alper B.S., Lewis P.R., Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?, J Fam Pract, 2000, 49, 255–264

    PubMed  CAS  Google Scholar 

  16. Lancaster T., Silagy C., Gray S., Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials, Br J Gen Pract, 1995, 45, 39–45

    PubMed  CAS  Google Scholar 

  17. Wood M.J., Johnson R.W., McKendrick M.W., Taylor J., Mandal B.K., Crooks J., A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster, N Engl J Med, 1994, 330, 896–900 DOI: 10.1056/NEJM199403313301304

    Article  PubMed  CAS  Google Scholar 

  18. Berry J.D., Petersen K.L., A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster, Neurology, 2005, 65, 444–447 DOI: 10.1212/01.wnl.0000168259.94991.8a

    Article  PubMed  CAS  Google Scholar 

  19. Schmader K., Herpes zoster in older adults, Clin Infect Dis, 2001, 32, 1481–1486 DOI: 10.1086/320169

    Article  PubMed  CAS  Google Scholar 

  20. Schmader K., George L.K., Burchett B.M., Pieper C.F., Hamilton J.D., Racial differences in the occurrence of herpes zoster, J Infect Dis, 1995, 171, 701–704

    Article  PubMed  CAS  Google Scholar 

  21. Okamoto S., Hata A., Sadaoka K., Yamanishi K., Mori Y., Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals, J Infect Dis, 2009, 200, 1606–1610 DOI: 10.1086/644646

    Article  PubMed  CAS  Google Scholar 

  22. Strangfeld A., Listing J., Herzer P., Liebhaber A., Rockwitz K., Richter C., et al., Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents, JAMA, 2009, 301, 737–744 DOI: 10.1001/jama.2009.146

    Article  PubMed  CAS  Google Scholar 

  23. Schuchter L.M., Wingard J.R., Piantadosi S., Burns W.H., Santos G.W., Saral R., Herpes zoster infection after autologous bone marrow transplantation, Blood, 1989, 74, 1424–1427

    PubMed  CAS  Google Scholar 

  24. Toyama N., Shiraki K., Society of the Miyazaki Prefecture D., Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture, J Med Virol, 2009, 81, 2053–2058 DOI: 10.1002/jmv.21599

    Article  PubMed  Google Scholar 

  25. Joesoef R.M., Harpaz R., Leung J., Bialek S.R., Chronic medical conditions as risk factors for herpes zoster, Mayo Clinic proceedings Mayo Clinic, 2012, 87, 961–967 DOI: 10.1016/j.mayocp.2012.05.021

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jurica Arapović.

About this article

Cite this article

Pezer, M., Vidić, V., Nikolić, J. et al. Risk factors in patients with herpes zoster infections: case-control study. cent.eur.j.med 8, 493–498 (2013). https://doi.org/10.2478/s11536-013-0155-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-013-0155-8

Keywords

Navigation